Company News
Laurus Labs Invests €9.8M in KRKA Pharma JV
Laurus Labs Board approves investment of €9.8M in its joint venture KRKA Pharma Private Limited.
Co-venturer KRKA d.d. will invest €10.2M, maintaining the existing 51:49 shareholding ratio.
Funds will